Clinical trial
Efficacy and Safety of Surinabant Treatment as an Aid to Smoking Cessation…
NCT00432575 · Sanofi, Industry · Completed
Key facts
| NCT number | NCT00432575 |
|---|---|
| Title | Efficacy and Safety of Surinabant Treatment as an Aid to Smoking Cessation (SURSMOKE) |
| Official title | A Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Fixed-Dose, 8-Week Treatment, Multi-Center Trial Evaluating the Efficacy and the Safety of 3 Oral Doses of Surinabant as an Aid to Smoking Cessation in Cigarette Smokers |
| Lead sponsor | Sanofi, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Smoking Cessation |
| Intervention type | Drug |
| Interventions | surinabant (SR147778), placebo |
| Enrollment | 810 |
| Start date | Jan 1, 2007 |
| Primary completion | Apr 1, 2008 |
| Completion | Apr 1, 2008 |
| First posted | Feb 8, 2007 |
| Last update posted | Apr 15, 2009 |
| Countries | Belgium, France, Germany, Italy, Norway, Spain, Sweden, Switzerland |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: